Literature DB >> 2189590

Cephalosporins increase the renal clearance of methotrexate and 7-hydroxymethotrexate in rabbits.

H Iven1, H Brasch.   

Abstract

Anaesthetized rabbits were infused with methotrexate (MTX; 30 micrograms x kg-1 x min-1) for 4 h. Constant plasma concentrations of MTX and its main metabolite 7-hydroxymethotrexate (7-OH-MTX) were achieved 40-60 min after the start of the infusion. In all, 50% of the infused MTX was eliminated by the kidney; another 15%-30% was hydroxylated and excreted as 7-OH-MTX in the urine. A concomitant infusion of penicillin G (3.96 mg x kg-1 x min-1) decreased the renal clearance of MTX and 7-OH-MTX, probably by competitive antagonism at the common tubular secretion site. In contrast, the four cephalosporins ceftriaxone, ceftazidime, ceftizoxime and cefoperazone all increased the renal clearance of MTX and 7-OH-MTX. At similar plasma concentrations, ceftriaxone and ceftazidime were almost equipotent, ceftizoxime was less effective and cefoperazone seemed to have a biphasic effect, depressing the clearance of MTX and 7-OH-MTX at higher drug concentrations. The effects are best explained by an inhibition of the tubular reabsorption of the cytostatic and its metabolite. The results suggest that cephalosporins are a better choice than penicillin for antibiotic treatment during MTX therapy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2189590     DOI: 10.1007/bf02897260

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  26 in total

1.  Drug interaction in psoriasis.

Authors:  J D Adams; G A Hunter
Journal:  Australas J Dermatol       Date:  1976-08       Impact factor: 2.875

2.  The synergistic effect of salicylates on methotrexate toxicity.

Authors:  M A Mandel
Journal:  Plast Reconstr Surg       Date:  1976-06       Impact factor: 4.730

3.  Biliary secretion of methotrexate in rats and its inhibition by probenecid.

Authors:  R E Kates; T N Tozer
Journal:  J Pharm Sci       Date:  1976-09       Impact factor: 3.534

Review 4.  High-dose methotrexate therapy--an area of uncertainty.

Authors:  J W Paxton
Journal:  Aust N Z J Med       Date:  1979-12

5.  The effect of organic acids on renal clearance of methotrexate in man.

Authors:  D G Liegler; E S Henderson; M A Hahn; V T Oliverio
Journal:  Clin Pharmacol Ther       Date:  1969 Nov-Dec       Impact factor: 6.875

6.  Inhibition of renal tubular transport of methotrexate by probenecid.

Authors:  R S Bourke; G Chheda; A Bremer; O Watanabe; D B Tower
Journal:  Cancer Res       Date:  1975-01       Impact factor: 12.701

Review 7.  The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.

Authors:  H C Neu
Journal:  Annu Rev Pharmacol Toxicol       Date:  1982       Impact factor: 13.820

8.  Interaction of probenecid with the protein binding of methotrexate.

Authors:  J W Paxton
Journal:  Pharmacology       Date:  1984       Impact factor: 2.547

9.  Protein binding of methotrexate in sera from normal human beings: effect of drug concentration, pH, temperature, and storage.

Authors:  J W Paxton
Journal:  J Pharmacol Methods       Date:  1981-05

10.  The comparative pharmacokinetics of ceftazidime and cefotaxime in healthy volunteers.

Authors:  S M Harding; A J Monro; J E Thornton; J Ayrton; M I Hogg
Journal:  J Antimicrob Chemother       Date:  1981-09       Impact factor: 5.790

View more
  4 in total

1.  Urinary coproporphyrin I/(I + III) ratio as a surrogate for MRP2 or other transporter activities involved in methotrexate clearance.

Authors:  Isabelle Benz-de Bretagne; Noël Zahr; Amélie Le Gouge; Jean-Sébastien Hulot; Caroline Houillier; Khe Hoang-Xuan; Emmanuel Gyan; Séverine Lissandre; Sylvain Choquet; Chantal Le Guellec
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

Review 2.  Pharmacokinetic drug interactions with anticancer drugs.

Authors:  P M Loadman; M C Bibby
Journal:  Clin Pharmacokinet       Date:  1994-06       Impact factor: 6.447

3.  Evaluation and Application of Population Pharmacokinetic Models for Identifying Delayed Methotrexate Elimination in Patients With Primary Central Nervous System Lymphoma.

Authors:  Junjun Mao; Qing Li; Pei Li; Weiwei Qin; Bobin Chen; Mingkang Zhong
Journal:  Front Pharmacol       Date:  2022-03-09       Impact factor: 5.810

4.  Ceftazidime and cefepime antagonize 5-fluorouracil's effect in colon cancer cells.

Authors:  Christina Pfab; Anush Abgaryan; Barbara Danzer; Fatme Mourtada; Weaam Ali; André Gessner; Nahed El-Najjar
Journal:  BMC Cancer       Date:  2022-01-31       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.